INOVIO PHARMACEUTICALS, INC. 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Mar 13, 2017
Insider Transaction Report
Form 4
Sardesai Niranjan
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2017-03-09$6.61/sh−7,648$50,553→ 80,865 total - Exercise/Conversion
Common Stock
2017-03-10+6,077→ 86,942 total - Tax Payment
Common Stock
2017-03-10$6.68/sh−1,859$12,418→ 85,083 total - Exercise/Conversion
Restricted Stock Unit
2017-03-09−25,000→ 50,000 total→ Common Stock (25,000 underlying) - Award
Common Stock Option
2017-03-10$6.68/sh+100,000$668,000→ 100,000 totalExercise: $6.68From: 2017-03-10Exp: 2027-03-10→ Common Stock (100,000 underlying) - Award
Restricted Stock Unit
2017-03-10+61,300→ 61,300 total→ Common Stock (61,300 underlying) - Exercise/Conversion
Common Stock
2017-03-09+25,000→ 88,513 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares will vest on March 9, 2018; 25,000 shares will vest on March 9, 2019. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- [F2]These restricted stock units vested 100% on the March 10, 2017 grant date.
- [F3]The vesting schedule for the 100,000 options is as follows: 25,000 shares vested on March 10, 2017; 25,000 shares will vest on March 10, 2018; 25,000 shares will vest on March 10, 2019; 25,000 shares will vest on March 10, 2020
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 61,300 restricted stock units is as follows: 20,433 shares will vest on March 10, 2018; 20,434 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.